Vaccinia recombinants as vaccine vectors.
Mahr
A
A
Applied bioTechnology, Cambridge, Massachusetts.
Payne
L G
LG
D000818:Animals; D004274:DNA, Recombinant / Q000627:therapeutic use; D005822:Genetic Vectors; D015658:HIV Infections / Q000517:prevention & control; D015497:HIV-1; D006509:Hepatitis B / Q000517:prevention & control; D006801:Humans; D008288:Malaria / Q000517:prevention & control; D011818:Rabies / Q000517:prevention & control; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; D014616:Vaccinia virus / Q000235:genetics* / Q000276:immunology
D004274:DNA, Recombinant; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic